Trademark: 97508583
Word
DIFFUSIO2N
Status Date
Monday, August 12, 2024
Filing Date
Monday, July 18, 2022
Published for Opposition
Tuesday, December 19, 2023
5 Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals
The mark consists of the letters and number in the following order with the "2" as a subscript: Diffusio2n.
Color is not claimed as a feature of the mark.
"DIFFUSION"
Jul 21, 2022
New Application Entered
Aug 9, 2022
New Application Office Supplied Data Entered
May 2, 2023
Assigned To Examiner
May 9, 2023
Non-Final Action Written
May 9, 2023
Non-Final Action E-Mailed
May 9, 2023
Notification Of Non-Final Action E-Mailed
Aug 9, 2023
Application Extension To Response Period - Received
Aug 9, 2023
Application Extension Granted/Receipt Provided
Nov 9, 2023
Teas Response To Office Action Received
Nov 9, 2023
Correspondence Received In Law Office
Nov 10, 2023
Teas/Email Correspondence Entered
Nov 15, 2023
Approved For Pub - Principal Register
Nov 29, 2023
Notification Of Notice Of Publication E-Mailed
Dec 19, 2023
Published For Opposition
Dec 19, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Noa E-Mailed - Sou Required From Applicant
Aug 12, 2024
Sou Teas Extension Received
Aug 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2024
Sou Extension 1 Granted
Aug 13, 2024
Sou Extension 1 Filed
Trademark Alertz updated from USPTO on 2030-01-24
